In the study by Rebbeck et al., HRT exposure had no impact on the reduction of breast cancer risk associated with RRBSO in BRCA1/2 mutation carriers (HR = 0.37; 95% CI 0.14–0.96) compared to the entire cohort. The gene discussed is BRCA1; the disease is breast carcinoma.